-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SUSfrtp8WAmIoZ1fAw+1XjFRRnQu7oUVfc6FHDumDM2qbi00DhKTCySMrl+CRsLB dhuFxkfCpHds8qbKaT//Fg== 0001243764-10-000002.txt : 20100309 0001243764-10-000002.hdr.sgml : 20100309 20100309125814 ACCESSION NUMBER: 0001243764-10-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100305 FILED AS OF DATE: 20100309 DATE AS OF CHANGE: 20100309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHMID HANS P CENTRAL INDEX KEY: 0001243764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 10666181 MAIL ADDRESS: STREET 1: 901 MARINERS ISLAND BLVD STREET 2: STE. 205 CITY: SAN MATEO STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-03-05 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001243764 SCHMID HANS P 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404 0 1 0 0 Pres & Mng Dir, SciClone Int'l Non-Qualified Stock Option (right to buy) 3.55 2010-03-05 4 A 0 80000 0 A 2020-03-05 Common Stock 80000 80000 D Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest one year from the date of grant, of March 5, 2010, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer. /s/ Gary Titus, Attorney-In-Fact 2010-03-09 EX-24 2 schmid.htm
LIMITED POWER OF ATTORNEY

FOR SECTION 16(a) REPORTING



 KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned

hereby makes, constitutes and appoints Friedhelm Blobel and Gary Titus,

and each of them, as the undersigned's true and lawful attorney-in-fact

(the "Attorney-in Fact"), with full power of substitution and

resubstitution, each with the power to act alone for the undersigned and

in the undersigned's name, place and stead, in any and all capacities to:



 1. prepare, execute, deliver and file with the United States

Securities and Exchange Commission, any national securities exchange and

SciClone Pharmaceuticals, Inc. (the "Company") any and all reports (including any

amendment thereto) of the undersigned required or considered advisable under

Section 16(a) of the Securities Exchange Act of 1934, as amended (the

"Exchange Act"), and the rules and regulations thereunder, with respect to

the equity securities of the Company, including Form 3 (Initial Statement of

Beneficial Ownership of Securities), Form 4 (Statement of Changes in

Beneficial Ownership), and Form 5 (Annual Statement of Changes in Beneficial

Ownership); and



 2. seek or obtain, as the undersigned's representative and on the

undersigned's behalf, information on transactions in the Company's equity

securities from any third party, including the Company, brokers, dealers,

employee benefit plan administrators and trustees, and the undersigned hereby

authorizes any such third party to release any such information to the

Attorney-in-Fact.



 The undersigned acknowledges that:



 1. this Limited Power of Attorney authorizes, but does not require,

the Attorney-in-Fact to act at his or her discretion on information provided to

such Attorney-in-Fact without independent verification of such information;



 2. any documents prepared and/or executed by the Attorney-in-Fact

on behalf of the undersigned pursuant to this Limited Power of Attorney will

be in such form and will contain such information as the Attorney-in-Fact, in

his or her discretion, deems necessary or desirable;



 3. neither the Company nor the Attorney-in-Fact assumes any

liability for the undersigned's responsibility to comply with the requirements

of Section 16 of the Exchange Act, any liability of the undersigned for any

failure to comply with such requirements, or any liability of the undersigned

for disgorgement of profits under Section 16(b) of the Exchange Act; and



 4. this Limited Power of Attorney does not relieve the undersigned

from responsibility for compliance with the undersigned's obligations under

Section 16 of the Exchange Act, including, without, limitation, the reporting

requirements under Section 16(a) of the Exchange Act.



 The undersigned hereby grants to the Attorney-in-Fact full power and

authority to do and perform each and every act and thing requisite, necessary

or convenient to be done in connection with the foregoing, as fully, to all

intents and purposes, as the undersigned might or could do in person, hereby

ratifying and confirming all that the Attorney-in-Fact, or his or her

substitute or substitutes, shall lawfully do or cause to be done by authority

of this Limited Power of Attorney.



 This Limited Power of Attorney shall remain in full force and effect

until the undersigned is no longer required to file Forms 3, 4 or 5 with

respect to the undersigned's holdings of and transactions in equity securities

of the Company, unless earlier revoked by the undersigned in a signed writing

delivered to the Attorney-in-Fact.



 This Limited Power of Attorney shall be governed and construed in

accordance the laws of the State of California without regard to the laws that

might otherwise govern under applicable principles of conflicts of laws

thereof.



 IN WITNESS WHEREOF, the undersigned has caused this Limited Power of

Attorney to be executed as of March 2, 2010.



Signature:  /s/ Hans Schmid



Print Name:  Hans Schmid



-----END PRIVACY-ENHANCED MESSAGE-----